Morgan Stanley’s Biodesix BDSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $361 | Sell |
1,278
-11,598
| -90% | -$3.28K | ﹤0.01% | 7495 |
|
|
2025
Q1 | $8.05K | Sell |
12,876
-27,400
| -68% | -$17.1K | ﹤0.01% | 6868 |
|
|
2024
Q4 | $61.6K | Buy |
40,276
+32,841
| +442% | +$50.2K | ﹤0.01% | 6227 |
|
|
2024
Q3 | $13.2K | Hold |
7,435
| – | – | ﹤0.01% | 6635 |
|
|
2024
Q2 | $11.4K | Sell |
7,435
-1,738
| -19% | -$2.66K | ﹤0.01% | 6631 |
|
|
2024
Q1 | $13.1K | Sell |
9,173
-11,097
| -55% | -$15.9K | ﹤0.01% | 6602 |
|
|
2023
Q4 | $37.3K | Buy |
20,270
+9,585
| +90% | +$17.6K | ﹤0.01% | 6465 |
|
|
2023
Q3 | $17.6K | Sell |
10,685
-8,443
| -44% | -$13.9K | ﹤0.01% | 6526 |
|
|
2023
Q2 | $23.5K | Sell |
19,128
-32,072
| -63% | -$39.4K | ﹤0.01% | 6515 |
|
|
2023
Q1 | $95.2K | Sell |
51,200
-997
| -2% | -$1.85K | ﹤0.01% | 6020 |
|
|
2022
Q4 | $120K | Sell |
52,197
-4,764
| -8% | -$11K | ﹤0.01% | 5897 |
|
|
2022
Q3 | $71K | Sell |
56,961
-16,928
| -23% | -$21.1K | ﹤0.01% | 6240 |
|
|
2022
Q2 | $122K | Buy |
73,889
+18,027
| +32% | +$29.8K | ﹤0.01% | 6168 |
|
|
2022
Q1 | $94K | Sell |
55,862
-9,433
| -14% | -$15.9K | ﹤0.01% | 6348 |
|
|
2021
Q4 | $345K | Sell |
65,295
-43,228
| -40% | -$228K | ﹤0.01% | 5767 |
|
|
2021
Q3 | $892K | Buy |
108,523
+64,919
| +149% | +$534K | ﹤0.01% | 5125 |
|
|
2021
Q2 | $575K | Buy |
43,604
+34,190
| +363% | +$451K | ﹤0.01% | 5442 |
|
|
2021
Q1 | $191K | Sell |
9,414
-26,429
| -74% | -$536K | ﹤0.01% | 5683 |
|
|
2020
Q4 | $722K | Buy |
+35,843
| New | +$722K | ﹤0.01% | 4849 |
|